对药物基因组学覆盖的战略见解:对阿联保险利益相关者的观点进行基于理论的SWOT分析
Maram O Abbas1, Azhar T Rahma1, Iffat Elbarazi1
1Institute of Public Health, College of Medicine & Health Sciences, United Arab Emirates University, Al Ain, UAE.
Human genomics
|December 30, 2025
概括
在阿联,药基因组 (PGx) 测试的采用受到成本和认识障碍的阻碍. 保险公司建议合作战略和明确的指导方针对于扩大PGx实施和改善患者护理至关重要.
科学领域:
- 药物基因组学 药物基因组学
- 卫生经济学 卫生经济学
- 卫生政策 卫生政策
背景情况:
- 药物遗传学 (PGx) 测试基于遗传特征个性化治疗,但面临全球实施挑战.
- 在阿联现有的PGx指导方针缺乏全面的保险公司观点.
- 了解保险商的观点对于克服PGx采用障碍至关重要.
研究的目的:
- 探索保险代表对阿联PGx采用的政策和策略的看法.
- 从保险人的角度来看,确定扩大PGx实施的障碍和促进者.
主要方法:
- 使用半结构面试对12名保险管理代表进行定性研究.
- 使用了主题分析,比较分析,机构理论,TAM和SWOT分析.
主要成果:
- 对于PGx的好处和重大障碍的认识变化,包括经济限制和有限的公众/医生意识.
- 确定了与成本效益和基础设施相关的政策挑战.
- 执行管理层专注于战略政策和投资回报率,而中层管理层则强调运营障碍.
结论:
- 在阿联推进PGx需要当地成本效益研究和政府主导的覆盖指南.
- 利益相关者之间的协作行动和分阶段采用战略是可持续实施的关键.
- 调查结果可以为类似的公私保险模式的医疗系统提供信息.
相关概念视频
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Issues And Trends In Healthcare Delivery System
6.1K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.1K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
153
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
153
Analysis of Population Pharmacokinetic Data
648
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
648
Pharmacokinetic Models: Overview
1.8K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.8K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
376
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
376


